Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A Study in Myeloproliferative Disorders

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by (Responsible Party):
Eli Lilly and Company
ClinicalTrials.gov Identifier:
NCT01134120
First received: May 27, 2010
Last updated: June 15, 2016
Last verified: June 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: August 2016
  Primary Completion Date: April 2014 (Final data collection date for primary outcome measure)